New Focused Ultrasound Device to Treat the Prostate Receives FDA Approval ,  Profound Medical recently announced that its TULSA-PRO® device has earned 510(k) clearance by the US Food and Drug Administration (FDA) to ablate prostate tissue. This is the first transurethral focused ultrasound device approved in the US, and it allows physicians to predictably ablate whole-gland or partial prostate tissue. READ MORE >